No evidence for enhanced adipocyte differentiation in patients with postmenopausal osteoporosis.

被引：0
|
作者：
Justesen, J
Stenderup, K
Steiniche, T
Eriksen, EF
Kassem, M
机构：
[1] Aarhus Kommune Hosp, Dept Endocrinol & Metab, Aarhus, Denmark
[2] Aarhus Univ, Aarhus Kommune Hosp, Inst Pathol, DK-8000 Aarhus, Denmark
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU177
引用
收藏
页码：S476 / S476
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Bazedoxifene in Postmenopausal Latino Women with Osteoporosis.
    Hernandez Bueno, Jose A.
    Arias, Lizbeth
    Yu, Ching-Ray
    Williams, Robert
    Komm, Barry S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S469 - S470
  • [22] Postmenopausal osteoporosis. Its validity as a current health problem
    Guzman Lopez, Katherine Natalie
    Pazmino Maya, Andrea De Las Mercedes
    Ortiz Granja, Luis Bolivar
    Ocana, Jessica
    REVISTA CUBANA DE REUMATOLOGIA, 2018, 20 (01):
  • [23] Risedronate is well-tolerated in women with postmenopausal osteoporosis.
    McClung, M
    Eastell, R
    Watts, N
    Fogelman, I
    Hooper, M
    Ernst, T
    Bettica, P
    Reginster, JY
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S538 - S538
  • [24] Physical activity around the age of 40 and postmenopausal osteoporosis.
    Randel, PA
    Kirkland, SA
    Joffres, MR
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S141 - S141
  • [25] Raloxifene is a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis.
    Jochems, C
    Islander, U
    Kallkopf, A
    Carlsten, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S161 - S161
  • [26] Prevention of postmenopausal osteoporosis. Part 1: Identification of patients at risk and nonhormone preventive measures
    Birkhaeuser, M.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2013, 11 (02): : 129 - 136
  • [27] Predictive factors for changes in spine deformity in relation to quality of life in patients with postmenopausal osteoporosis.
    Scholz, M
    Lazarescu, AD
    Pospeschill, M
    Makosch, S
    Hass, K
    Begerow, B
    Pfeifer, M
    Schlotthauer, T
    Pollaehne, W
    Minne, HW
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F556 - F556
  • [28] Recent advances in our understanding of the pathogenesis of male and postmenopausal osteoporosis.
    Khosla, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (06) : 1053 - 1053
  • [29] The therapeutic effects of the bisphosphonate evaluated by quantitative ultrasonography in postmenopausal osteoporosis.
    Rhee, Y
    Park, H
    Park, K
    Lim, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S412 - S412
  • [30] Consistency of effect of alendronate in glucocorticoid-induced and postmenopausal osteoporosis.
    Ernkey, R
    Saag, K
    Brown, J
    Correa-Rotter, R
    Malice, MP
    Carofano, W
    Dalfotis, A
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S44 - S44
12345